Innovation Pharmaceuticals Inc (IPIX)

[wsbc]

Would likely need to begin with RBL testing of a reformulated aerosolized compound. At the rate we're seeing RBL 'progress'... I'd say somewhere between 6-12mo for a possible reformulation. (depending on lab priority)

+

a mandatory P1 with the new reform- 2-3mo?

+ FDA review (2-6mo)

+ P2 for the reformulated compound- current trial: 6-8mo to topline?

+ FDA review etc (2-6mo)

+ P3 2yrs... with a possible interim @ 30-90 days?

Could be as fast as 3yrs?

I feel like everything depends on what happens with the current P2. Hoping this changes hands and is more capably and expediently progressed by an entity with the necessary credentials, funding, sales/distro and stability.

Anyone venture a scholarly opinion as to when Brilacidin will be available to be given prophylactically to unvaccinated, non infected adults looking for alternates to vaccines. Of course it would be conditioned on EUA, manufacturing, distribution and prioritization of patient populations. Are we looking at 6 mo, 12, 18 mo? Thanks in advance.